Haloperidol Richter (Haloperidol)

Haloperidol Richter is prescribed for several acute and chronic psychiatric presentations where rapid control of symptoms is required.

• Schizophrenia, particularly when oral therapy is insufficient or rapid symptom control is needed.
• Acute psychotic episodes, including those associated with substance use or medical illness.
• Severe agitation or aggression that requires intramuscular administration for quick effect.
• Manic episodes of bipolar disorder when oral agents are not feasible.
• Behavioral disturbances in patients with dementia or developmental disorders, used under close supervision.

Side effects reported with intramuscular haloperidol vary in frequency and severity; they are categorized as common or serious based on clinical observations.

Common

• Drowsiness or sedation, which may affect alertness and coordination.
• Extrapyramidal symptoms such as tremor, muscle rigidity, or akathisia (restlessness).
• Dry mouth and increased salivation, leading to discomfort in the oral cavity.
• Constipation or gastrointestinal discomfort, including reduced bowel movements.
• Orthostatic hypotension, causing dizziness when standing up quickly.

Serious

• Neuroleptic malignant syndrome, a rare but life‑threatening reaction characterized by fever, muscle rigidity, and autonomic instability.
• Severe extrapyramidal reactions that may require medical intervention, such as acute dystonia.
• Cardiac arrhythmias, including QT interval prolongation that can predispose to torsades de pointes.
• Tardive dyskinesia, a potentially irreversible movement disorder with prolonged use.
• Significant hypotension leading to syncope or falls.

When prescribing Haloperidol Richter, clinicians consider several precautionary measures to minimize risks and ensure safe use.

• Assess patient history for cardiovascular disease, as haloperidol may affect heart rhythm.
• Monitor for signs of extrapyramidal symptoms, especially during the initial treatment period.
• Use caution in patients with a history of seizures or neurologic disorders.
• Evaluate liver and kidney function before initiating therapy, adjusting dose if impairment is present.
• Avoid use in patients with known hypersensitivity to haloperidol or other butyrophenones.
• Consider pregnancy and lactation status; safety data are limited, and benefits must outweigh potential risks.

Haloperidol Richter can interact with other medicines; understanding which combinations to avoid or to use cautiously helps prevent adverse effects.

Avoid

• Concomitant use with other dopamine antagonists, which may increase the risk of extrapyramidal symptoms and sedation.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can raise haloperidol plasma concentrations.
• QT‑prolonging agents such as certain antiarrhythmics, antipsychotics, or macrolide antibiotics, which may exacerbate cardiac rhythm disturbances.

Use with caution

• CNS depressants, including benzodiazepines or opioids, as additive sedation may occur.
• Anticholinergic drugs, which can mask early signs of extrapyramidal side effects.
• Lithium therapy, requiring close monitoring for neurotoxicity.